<DOC>
	<DOCNO>NCT00041613</DOCNO>
	<brief_summary>There need treatment option patient recurrent squamous cell cancer head neck ( SCCHN ) . These tumor usually variety genetic defect include disruption p53 pathway , pathway would ordinarily work prevent development tumor . In study transfer p53 gene tumor cell use modify adenovirus ( INGN 201 ) compare methotrexate patient fail surgery , radiotherapy chemotherapy platinum taxanes .</brief_summary>
	<brief_title>Study Compare Overall Survival Patients Receiving INGN 201 ( Study Drug ) With Patients Receiving Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<criteria>18 year old Not eligible surgery Must radiation chemotherapy treatments No prior methotrexate treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Refractory Squamous Cell Carcinoma Head Neck</keyword>
</DOC>